PureTech Health plc - American Depositary Shares (PRTC)
Frequently Asked Questions About PureTech Health plc - American Depositary Shares (PRTC)
How can investors learn more about PureTech Health?
Investors can learn more about PureTech Health by visiting the company’s official website, where they can find comprehensive information on its pipeline, financial performance, and corporate activities. Additionally, PureTech regularly publishes press releases and participates in investor conferences to communicate updates and engage with the investment community.
How does PureTech Health fund its research and development?
PureTech Health funds its research and development activities through a combination of public and private investments, partnerships with other pharmaceutical companies, and collaborations with academic institutions. This diversified funding approach enables the company to pursue multiple therapeutic candidates simultaneously.
How does PureTech Health handle intellectual property?
PureTech Health takes intellectual property (IP) management seriously, recognizing its importance in protecting its innovations and maintaining a competitive edge. The company actively seeks to secure patents and other IP rights for its technologies and discoveries to safeguard its research and development investments.
How does PureTech Health's business model work?
PureTech Health's business model is focused on innovation and collaboration. The company develops its own therapeutics while also identifying opportunities to partner with other organizations to co-develop or license therapies, thus diversifying its revenue streams and maximizing the potential for successful product launches.
Is PureTech Health involved in any clinical trials?
Yes, PureTech Health is actively involved in various clinical trials as it progresses its therapeutic candidates through the development pipeline. The company conducts trials to evaluate the safety and efficacy of its treatments in patients, contributing to the advancement of medical science.
What are American Depositary Shares (ADS)?
American Depositary Shares (ADS) represent shares in foreign companies traded on U.S. exchanges. In the case of PureTech Health plc, each ADS represents a specific number of ordinary shares, allowing U.S. investors to buy shares in the company in a convenient format while complying with U.S. regulations.
What are PureTech's corporate social responsibility initiatives?
PureTech Health is committed to various corporate social responsibility (CSR) initiatives aimed at promoting health and well-being in communities. The company often engages in partnerships that foster innovation in healthcare, support health education, and contribute to research that can improve global health outcomes.
What are the key corporate values of PureTech Health?
PureTech Health is guided by core corporate values that emphasize innovation, integrity, and collaboration. The company strives to maintain a culture of excellence and drive its mission to develop impactful therapies while fostering a supportive and inclusive environment for its employees.
What are the main therapeutic areas of focus for PureTech?
PureTech Health primarily focuses on developing therapies in the areas of neurology, immunology, and oncology. The company targets diseases with high unmet medical needs and aims to deliver treatments that significantly improve patient outcomes.
What does PureTech Health plc do?
PureTech Health plc is a Boston-based biopharmaceutical company that focuses on developing innovative therapies for patients with serious diseases. The company utilizes its unique 'PureTech Platform' to discover and advance multiple therapeutic approaches across various therapeutic areas, including neurology, immunology, and oncology.
What is PureTech's approach to partnerships?
PureTech Health adopts a collaborative approach to partnerships, seeking to work with pharmaceutical companies, academic institutions, and other biotechs. Such collaborations enable PureTech to leverage external expertise and resources to accelerate its drug development efforts and enhance its portfolio.
What is PureTech's approach to patient-centricity?
PureTech Health emphasizes a patient-centric approach in its development processes by engaging with patients and healthcare providers to understand their needs and preferences. This feedback informs their research and therapeutic strategies, ensuring that the products developed address the real-world challenges faced by patients.
What is the mission of PureTech Health?
The mission of PureTech Health is to improve the lives of patients by creating and advancing transformative medicines. The company aims to tackle unmet medical needs by leveraging its proprietary technologies and collaborative partnerships in drug development.
What is the PureTech Platform?
The PureTech Platform is an integrated ecosystem that encompasses a range of novel technologies and operational capabilities aimed at accelerating drug discovery and development. This platform supports the creation and advancement of differentiated medicines by leveraging insights from multiple disciplines.
What regulatory approvals has PureTech Health received?
PureTech Health has received various regulatory approvals for its products, allowing it to conduct clinical trials and pursue commercialization in different markets. The company works closely with regulatory agencies to ensure compliance and safety in the development and marketing of its therapies.
What types of products does PureTech Health develop?
PureTech Health develops a range of biopharmaceutical products, including therapeutic drugs and treatment platforms targeting various serious diseases. The company is particularly focused on developing novel therapies that harness the immune system and other advanced biological mechanisms.
When was PureTech Health founded?
PureTech Health was founded in 2006. Since then, the company has dedicated itself to building a diverse portfolio of therapeutics and platforms that address significant health challenges through innovative science and technology.
Where is PureTech Health headquartered?
PureTech Health is headquartered in Boston, Massachusetts, a hub for biotechnology and pharmaceuticals. This strategic location allows the company to be at the forefront of scientific innovation and to readily collaborate with leading research institutions and companies in the field.
Who are the founders of PureTech Health?
PureTech Health was co-founded by Dr. Daphne Koller, Dr. George Yancopoulos, and Dr. David F. Artis. These visionaries brought together their expertise in medicine, immunology, and biotechnology to build a company focused on groundbreaking therapies for serious diseases.
Who is the CEO of PureTech Health?
As of my last data update, the CEO of PureTech Health is Dr. Dana D. L. K. McGowan. She leads the company in its mission to develop transformative therapies and is instrumental in driving the strategic direction of the organization.
What is the current price of PureTech Health plc - American Depositary Shares?
The current price of PureTech Health plc - American Depositary Shares is 16.90
When was PureTech Health plc - American Depositary Shares last traded?
The last trade of PureTech Health plc - American Depositary Shares was at 11:23 am EDT on September 26th, 2025